Skip to main content

Bicara Therapeutics Inc.

BCAX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0002023658

In the last 90 days, Bicara Therapeutics Inc. insiders filed 0 open-market purchases and 7 sales; 171 institutions reported holding it in 13F filings for Q2 2026, worth $2.07B in total; no superinvestor holds it.

13F holders, Q4 2025

Institutional positions in Bicara Therapeutics Inc. as of Dec 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
140
+27 vs. Q3 2025
Shares held
57.1M
+6.89M (+13.7%) vs. Q3 2025
Total value
$960.7M
+$168.2M (+21.2%) vs. Q3 2025
New holders
44
45 more added
Sold out
17
35 more reduced

1 institution that held it in Q3 2025 haven't filed for Q4 2025 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q3 2025: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting BCAX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ4 2025: 140 institutions
Q1 2021: 0 institutionsQ2 2021: 0 institutionsQ3 2021: 0 institutionsQ4 2021: 0 institutionsQ1 2022: 0 institutionsQ2 2022: 0 institutionsQ3 2022: 0 institutionsQ4 2022: 0 institutionsQ1 2023: 0 institutionsQ2 2023: 0 institutionsQ3 2023: 0 institutionsQ4 2023: 0 institutionsQ1 2024: 0 institutionsQ2 2024: 0 institutionsQ3 2024: 69 institutionsQ4 2024: 84 institutionsQ1 2025: 93 institutionsQ2 2025: 106 institutionsQ3 2025: 114 institutionsQ4 2025: 140 institutionsQ1 2026: 145 institutionsQ2 2026: 171 institutions
Value heldQ4 2025: $960.7M
Q1 2021: $0Q2 2021: $0Q3 2021: $0Q4 2021: $0Q1 2022: $0Q2 2022: $0Q3 2022: $0Q4 2022: $0Q1 2023: $0Q2 2023: $0Q3 2023: $0Q4 2023: $0Q1 2024: $0Q2 2024: $0Q3 2024: $927.6MQ4 2024: $813.6MQ1 2025: $633.9MQ2 2025: $475.3MQ3 2025: $792.5MQ4 2025: $960.7MQ1 2026: $1.35BQ2 2026: $2.07B
Institutions holding BCAX and their total value by quarter
QuarterHoldersValue
Q2 2026171$2.07B
Q1 2026145$1.35B
Q4 2025140$960.7M
Q3 2025114$792.5M
Q2 2025106$475.3M
Q1 202593$633.9M
Q4 202484$813.6M
Q3 202469$927.6M
Q2 20240$0
Q1 20240$0
Q4 20230$0
Q3 20230$0
Q2 20230$0
Q1 20230$0
Q4 20220$0
Q3 20220$0
Q2 20220$0
Q1 20220$0
Q4 20210$0
Q3 20210$0
Q2 20210$0
Q1 20210$0

Institutions, Q4 2025

Shares, value and share of portfolio for each institution holding Bicara Therapeutics Inc.; share changes are against Q3 2025.

Institutions holding BCAX in Q4 2025
InstitutionSharesValue% of portfolioChange in sharesAction
Napean Trading & Investment Co (Singapore) PTE Ltd113,780$1.91M0.37%−162,162−58.8%Reduced
Deutsche Bank AG128,626$2.16M0.00%+1,171+0.9%Added
D. E. Shaw & Co., Inc.136,522$2.30M0.00%+136,522New
Hudson Bay Capital Management LP150,000$2.52M0.01%+150,000New
UBS Group AG192,191$3.23M0.00%+94,829+97.4%Added
OrbiMed Advisors LLC209,100$3.52M0.07%+209,100New
Woodline Partners LP232,690$3.92M0.02%−116,000−33.3%Reduced
Northern Trust Corp237,107$3.99M0.00%−23,759−9.1%Reduced
TD Asset Management Inc244,626$4.12M0.00%+59,644+32.2%Added
DAFNA Capital Management LLC261,583$4.40M1.02%−55,418−17.5%Reduced
Charles Schwab Investment Management Inc272,145$4.58M0.00%−8,731−3.1%Reduced
Palo Alto Investors LP298,575$5.03M0.70%+298,575New
Clearbridge Investments, LLC298,762$5.03M0.00%−25,559−7.9%Reduced
Algert Global LLC318,269$5.36M0.08%+300,679+1,709.4%Added
Bank of America Corp335,682$5.65M0.00%−120,939−26.5%Reduced
Nan Fung Trinity (HK) Ltd372,385$6.27M0.50%−12,500−3.2%Reduced
Ensign Peak Advisors, Inc401,444$6.76M0.01%+401,444New
Rock Springs Capital Management LP429,095$7.22M0.37%+58,429+15.8%Added
Millennium Management LLC434,699$7.32M0.01%−580,193−57.2%Reduced
Goldman Sachs Group Inc552,331$9.30M0.00%+319,570+137.3%Added
Aisling Capital Management LP568,919$9.57M2.00%00.0%Unchanged
Acorn Capital Advisors, LLC643,382$10.8M3.67%00.0%Unchanged
FIL Ltd758,493$12.8M0.01%−45,260−5.6%Reduced
Citadel Advisors LLC772,258$13.0M0.01%+772,258New
Geode Capital Management, LLC811,400$13.7M0.00%−19,808−2.4%Reduced
Price T Rowe Associates Inc1,559,535$26.2M0.00%−195,876−11.2%Reduced
Franklin Resources Inc1,620,025$27.3M0.01%+1,620,025New
State Street Corp1,649,537$27.8M0.00%+1,059,260+179.5%Added
Vanguard Group Inc2,186,150$36.8M0.00%−14,775−0.7%Reduced
Omega Fund Management, LLC2,204,650$37.1M12.95%00.0%Unchanged
BlackRock, Inc.2,528,451$42.6M0.00%+216,662+9.4%Added
Deep Track Capital, LP2,614,004$44.0M1.00%+187,347+7.7%Added
Janus Henderson Group PLC2,646,285$44.5M0.02%+2,646,285New
TPG GP A, LLC3,010,425$50.7M1.89%00.0%Unchanged
Red Tree Management, LLC3,170,509$53.4M48.94%00.0%Unchanged
T. Rowe Price Investment Management, Inc.3,236,595$54.5M0.03%+2,771,868+596.5%Added
FMR LLC3,347,223$56.3M0.00%+648,862+24.0%Added
Vestal Point Capital, LP3,575,000$60.2M2.21%−1,525,000−29.9%Reduced
Siren, L.L.C.5,216,969$87.8M2.62%00.0%Unchanged
Ra Capital Management, L.P.6,955,993$117.1M1.20%00.0%Unchanged
Blackstone Group Inc.0$00.00%−1,224,336−100.0%Sold out
Schonfeld Strategic Advisors LLC0$00.00%−504,085−100.0%Sold out
Sectoral Asset Management Inc0$00.00%−266,495−100.0%Sold out
Silverarc Capital Management, LLC0$00.00%−250,606−100.0%Sold out
Superstring Capital Management LP0$00.00%−175,902−100.0%Sold out
Schroder Investment Management Group0$00.00%−173,651−100.0%Sold out
Marshall Wace, LLP0$00.00%−112,086−100.0%Sold out
Cantor Fitzgerald, L. P.0$00.00%−100,000−100.0%Sold out
Sphera Funds Management Ltd.0$00.00%−85,747−100.0%Sold out
Raymond James Financial Inc0$00.00%−67,701−100.0%Sold out
ExodusPoint Capital Management, LP0$00.00%−53,882−100.0%Sold out
Cinctive Capital Management LP0$00.00%−41,849−100.0%Sold out
Point72 Asset Management, L.P.0$00.00%−30,138−100.0%Sold out
Jain Global LLC0$00.00%−26,179−100.0%Sold out
Caxton Corp0$00.00%−10,941−100.0%Sold out
Federated Hermes, Inc.0$00.00%−667−100.0%Sold out
SBI Securities Co., Ltd.0$00.00%−1−100.0%Sold out
Point72 Europe (London) LLP––––Not filed